SWK Holdings, a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, signed a four-year credit facility with First Horizon Bank.
Aziyo Biologics, a biologics company with a portfolio of regenerative products aimed at improving compatibility between medical devices and the patients they treat, received an additional $4 million term loan from SWK Holdings Corporation, a healthcare-focused investment firm.
SWK Holdings, a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, signed the fifth amendment to the loan and security agreement with Cadence Bank.
Aziyo Biologics, a commercial-stage regenerative medicine company, entered into a $25 million credit facility from SWK Holdings.
BIOLASE entered into an amendment to its senior secured term loan with SWK Funding. The amendment extends the interest-only period of the loan by two quarters to November 2023 and reduces the minimum consolidated unencumbered liquid assets from $7.5 million to $5.5 million.
Acerus Pharmaceuticals entered into an amended agreement related to its existing credit facility with SWK, changing four aspects of its terms and conditions.
Hooper Holmes d/b/a Provant Health entered into an asset purchase agreement with Summit Health as part of a 363 sale. SWK Holdings and CNH Finance agreed to provide the company with up to $13.6 million in financing to keep the business operating until the sale closes.